Herbert JM - Search Results

1

Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin.

Savi P, Chong BH, Greinacher A, Gruel Y, Kelton JG, Warkentin TE, Eichler P, Meuleman D, Petitou M, Herault JP, Cariou R, Herbert JM. Savi P, et al. Among authors: herbert jm. Blood. 2005 Jan 1;105(1):139-44. doi: 10.1182/blood-2004-05-2010. Epub 2004 Sep 23. Blood. 2005. PMID: 15388575 Free article. Clinical Trial.

2

Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis.

Savi P, Herbert JM. Savi P, et al. Among authors: herbert jm. Semin Thromb Hemost. 2005 Apr;31(2):174-83. doi: 10.1055/s-2005-869523. Semin Thromb Hemost. 2005. PMID: 15852221 Review.

3

Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration.

Favier B, Alam A, Barron P, Bonnin J, Laboudie P, Fons P, Mandron M, Herault JP, Neufeld G, Savi P, Herbert JM, Bono F. Favier B, et al. Among authors: herbert jm. Blood. 2006 Aug 15;108(4):1243-50. doi: 10.1182/blood-2005-11-4447. Epub 2006 Apr 18. Blood. 2006. PMID: 16621967 Free article.

4

The synthetic pentasaccharide fondaparinux: first in the class of antithrombotic agents that selectively inhibit coagulation factor Xa.

Petitou M, Duchaussoy P, Herbert JM, Duc G, El Hajji M, Branellec JF, Donat F, Necciari J, Cariou R, Bouthier J, Garrigou E. Petitou M, et al. Among authors: herbert jm. Semin Thromb Hemost. 2002 Aug;28(4):393-402. doi: 10.1055/s-2002-34309. Semin Thromb Hemost. 2002. PMID: 12244487 Review.

5

P2Y12, a new platelet ADP receptor, target of clopidogrel.

Herbert JM, Savi P. Herbert JM, et al. Semin Vasc Med. 2003 May;3(2):113-22. doi: 10.1055/s-2003-40669. Semin Vasc Med. 2003. PMID: 15199474 Review.

6

Use of radiolabeled 2-methylthio-ADP to study P2Y receptors on platelets and cell lines.

Savi P, Herbert JM. Savi P, et al. Among authors: herbert jm. Methods Mol Biol. 2004;273:115-24. doi: 10.1385/1-59259-783-1:115. Methods Mol Biol. 2004. PMID: 15308797 No abstract available.

7

The antiaggregating activity of clopidogrel is not affected by N-acetyl L-cysteine.

Lalé A, Herbert JM, Savi P. Lalé A, et al. Among authors: herbert jm. Thromb Haemost. 2003 Nov;90(5):839-43. doi: 10.1160/TH03-01-0001. Thromb Haemost. 2003. PMID: 14597979

8

Effects of SanOrg123781A, a synthetic hexadecasaccharide, in a mouse model of electrically induced carotid artery injury: synergism with the antiplatelet agent clopidogrel.

Lorrain J, Lechaire I, Gauffeny C, Masson R, Roome N, Herault JP, O'Connor SE, Schaeffer P, Herbert JM. Lorrain J, et al. Among authors: herbert jm. J Pharmacol Exp Ther. 2004 Apr;309(1):235-40. doi: 10.1124/jpet.103.059873. Epub 2004 Jan 12. J Pharmacol Exp Ther. 2004. PMID: 14718579

9

Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.

Olson ST, Swanson R, Raub-Segall E, Bedsted T, Sadri M, Petitou M, Hérault JP, Herbert JM, Björk I. Olson ST, et al. Among authors: herbert jm. Thromb Haemost. 2004 Nov;92(5):929-39. doi: 10.1160/TH04-06-0384. Thromb Haemost. 2004. PMID: 15543318

10

VEGF-R2 and neuropilin-1 are involved in VEGF-A-induced differentiation of human bone marrow progenitor cells.

Fons P, Herault JP, Delesque N, Tuyaret J, Bono F, Herbert JM. Fons P, et al. Among authors: herbert jm. J Cell Physiol. 2004 Sep;200(3):351-9. doi: 10.1002/jcp.20076. J Cell Physiol. 2004. PMID: 15254962

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

439 results

Search Page